ArticleJournal of medical case reports2025
Malignant hyperthermia: patient undergoing limb debridement surgery-a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalignant hyperthermia is a rare but potentially fatal clinical emergency, primarily triggered by inhaled volatile anesthetics. It is associated with inherited autosomal-dominant skeletal muscle disorders and typically caused by mutations in muscle calcium channel genes. Owing to its rapid onset and severe complications, prompt diagnosis and intervention are crucial. This case report highlights a unique instance of malignant hyperthermia, emphasizing the importance of early detection and timely treatment in saving a patient's life. CASE PRESENTATION: A 30-year-old Han Chinese male underwent limb debridement surgery twice within 4 days, and, during the second surgery, he developed signs of malignant hyperthermia following the administration of inhaled anesthetics. The patient presented with hyperthermia, tachycardia, hypercapnia, and masseter spasm. Clinical diagnosis of malignant hyperthermia was confirmed, and immediate treatment with dantrolene was initiated. A multidisciplinary approach was employed to manage the condition, leading to successful stabilization and recovery. The patient ultimately made a full recovery without further complications. After the surgery, the patient underwent genetic testing, and no clear pathogenic genes were found; however, there were some suspicious related genes.
conclusionThis case underscores the critical importance of the early recognition of malignant hyperthermia and the prompt administration of dantrolene, which is vital in mitigating its life-threatening consequences. It also highlights the need for thorough preoperative screening for patients at risk of malignant hyperthermia and suggests improvements in treatment protocols to optimize patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.